Elicio Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Elicio Therapeutics, Inc. (ELTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 212.91 thousand shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2022-05-16
- Elicio Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2022-03-31 was 212.91K shares, a 111370.68% increase year-over-year.
- Elicio Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2021-12-31 was 10.77K shares.
- Elicio Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2021-09-30 was 0.00 shares.
- Elicio Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2021-06-30 was 0.00 shares.
- Elicio Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2021 was 10.96K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2022-03-31 | 212.91K shares 10-Q · filed 2022-05-16 | 223.68K shares derived: sum of 2 quarters · filed 2022-05-16 | 223.68K shares derived: sum of 3 quarters · filed 2022-05-16 | 223.68K shares derived: sum of 4 quarters · filed 2022-05-16 |
| 2021-12-31 | 10.77K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 10.77K shares derived: sum of 2 quarters · filed 2022-03-30 | 10.77K shares derived: sum of 3 quarters · filed 2022-03-30 | 10.96K shares 10-K · filed 2022-03-30 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2021-11-12 | 191.00 shares 10-Q · filed 2021-11-12 | |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 191.00 shares 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | 191.00 shares 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |